Moreover, a recent study has demonstrated that long-term overexpression of AAV9-SMN1 in a SMA mouse model induces a dose-dependent late-onset motor dysfunction characterized by loss of proprioceptive synaptic transmission and neurodegeneration. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.